Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Emily Singer Guest Contributor

I write about the brain and other strange natural phenomena.

  • Better Drug-Producing Bacteria

    A synthetically engineered strain of E. coli, stripped of non-essential parts, could boost the bug’s industrial power.

    9 comments

  • Stem Cells Reborn

    In the wake of scientific fraud in South Korea, researchers are renewing their race to clone stem cells.

  • Safer Gene Therapy

    A gene therapy pioneer explains how new delivery mechanisms could help revive the once-promising technology.

    2 comments

  • Cheaper Malaria Drugs

    Synthetically engineered microorganisms could provide a much cheaper way to manufacture drugs.

  • Genomics Into Drugs

    Kari Stefansson, founder and CEO of deCode Genetics, explains why gene hunting provides tailor-made drug targets.

  • Gene Hunting in Canada

    Genizon is using the genetic homogeneity of French Canadians to find new drug targets – and redefine human disease.

  • Spotting Alzheimer's Early

    A new type of PET imaging technique could eventually help doctors diagnose and head off the disease before symptoms appear.

    2 comments

Pages

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me